Watch our videos on YouTube showing:
- How to register your study
- How to request an update to your study record
- How to report your study results
The full playlist can be found here.
ISRCTN registry
ISRCTN is a clinical trial registry recognized by the WHO and ICMJE that accepts planned, ongoing or completed studies of any design. ISRCTN is committed to supporting research transparency. The first ISRCTN numbers were issued in 2000, so in 2025 we will celebrate 25 years of ISRCTN.
Why register with us?
- Our expert editors work with investigators to ensure that study records are clear and complete before publication
- We send prompts to update records at key milestones
- ISRCTN records include basic results summaries, protocols, published results links and data-sharing plans
- ISRCTN records encourage public involvement by including plain English summaries and appear on the WHO ICTRP and Be Part of Research portals
Announcing our new Transparency Tracker and Badges
We’re excited to present the release of the ISRCTN clinical study registry’s new and improved Transparency Tracker and Badges. We’ve put together a handy guide.
Read MoreKey takeaways from our recent NIHR conference attendance
In April, we had the privilege of attending the National Institute for Health and Care Research (NIHR) School for Social Care Research (SSCR) Annual Conference 2024.
Read MoreConference posters
Instruction videos on YouTube
Our partnership with the Health Research Authority (HRA)
All Clinical Trials of Investigational Medicinal Products (CTIMPs) in the UK that receive a favourable research ethics committee (REC) opinion are automatically submitted to ISRCTN using data from the HRA’s systems, meaning that trialists and sponsors do not have to apply for registration separately.
The partnership creates a simplified process for registration, takes the burden away from research sponsors and researchers, and ensures that information about the trials is publicly available for the benefit of all.
The partnership is part of the HRA's Make it Public strategy and also supports the UK’s commitments to the G7 Therapeutics and Vaccines Clinical Trials Charter. Please see the HRA’s combined review guidance here and our statement here.
If you have any queries, please contact us at info@isrctn.com.